- Presentations
- 3
- Markets
- 1
Doxil is a brand of Doxorubicin marketed by Baxter Healthcare, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Doxorubicin
- Brand owner
- Baxter Healthcare
- Registered in
- United States
- Strengths and forms
- 20 mg/10 mL liposomal injectable suspension, 50 mg/25 mL liposomal injectable suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Doxil 20 mg/10 mL liposomal injectable suspensionIntravenous Cold chain | Baxter Healthcare | US FDA | Available on request |
| Doxil 50 mg/25 mL liposomal injectable suspensionIntravenous Cold chain | Baxter Healthcare | US FDA | Available on request |
| Doxil 50 mg/25 mL liposomal injectable suspensionIntravitreal Cold chain | Baxter Healthcare | US FDA | Available on request |
Equivalent brands
Other brands of Doxorubicin.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Doxil
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.